We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 384

Court rejects “swapping” claims, rejects claim that “below cost” discounting violates the Anti-Kickback Statute

  • Sidley Austin LLP
  • -
  • USA
  • -
  • August 26 2014

The Southern District of Ohio recently granted defendants' motion to dismiss in a FCA case based on alleged violations of the Anti-Kickback Statute

8th Circuit affirms dismissal of FCA claim, offering guidance on the application of the public disclosure bar

  • Sidley Austin LLP
  • -
  • USA
  • -
  • August 18 2014

On August 7, 2014, the Eighth Circuit affirmed the dismissal of a qui tam False Claims Act suit, and in doing so offered helpful guidance regarding

China Human Genetic Resources Administration Office asserts authority to approve clinical studies sponsored by foreign companies in China involving human sample collection

  • Sidley Austin LLP
  • -
  • China
  • -
  • August 13 2014

The China Human Genetic Resources Administration Office (CHGRAO) recently indicated informally that clinical studies sponsored by foreign companies

9th Circuit affirms dismissal of FCA claim as “implausible” where defendant disclosed its disputed billing methodology to the government

  • Sidley Austin LLP
  • -
  • USA
  • -
  • July 25 2014

On July 22, 2014, the Ninth Circuit issued an important decision supporting the principle that good faith disputes about ambiguous or disputed

New FDA informed consent draft guidance broadens scope of sponsor disclosure obligations

  • Sidley Austin LLP
  • -
  • USA
  • -
  • July 22 2014

On July 15, 2014, the U.S. Food and Drug Administration ("FDA" or the "Agency") issued a draft guidance document, entitled "Informed Consent

DOJ seeks aggressive enforcement of FCA overpayment provision

  • Sidley Austin LLP
  • -
  • USA
  • -
  • July 10 2014

On June 27, 2014, the Department of Justice ("DOJ") elected to intervene in a FCA suit based solely on an alleged failure to timely refund

New MDDS guidance reduces regulatory hurdles for developers

  • Sidley Austin LLP
  • -
  • USA
  • -
  • July 9 2014

The Food and Drug Administration has issued draft guidance announcing that it does not intend to enforce compliance with the regulatory controls that

OIG issues Special Fraud Alert regarding laboratory relationships with physicians

  • Sidley Austin LLP
  • -
  • USA
  • -
  • June 30 2014

On June 25, 2014, the U.S. Department of Health and Human Services' Office of Inspector General ("OIG") released a Special Fraud Alert addressing two

Court order compelling FCA defendant to produce documents previously produced to HHS OIG warns of limitations of confidentiality agreements

  • Sidley Austin LLP
  • -
  • USA
  • -
  • June 26 2014

On May 29, 2014, the United States District Court for the Southern District of Illinois ordered K-Mart Corporation to produce documents to a relator

New FDA MDDS draft guidance reduces regulatory hurdles for software developers, signals continued intent to “regulate” software via policy

  • Sidley Austin LLP
  • -
  • USA
  • -
  • June 25 2014

On June 20, 2014, FDA issued a draft guidance titled "Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications